Kemin Industries has acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, Michigan, US.
“The acquisition of this beta-glucan manufacturing technology, developed by Algal Scientific, will provide Kemin with capabilities and products needed to further expand our antibiotic alternative portfolio for animals, and offer important scientific advancements for humans and pets,” said Dr. Chris Nelson, president and CEO of Kemin Industries.
Algal Scientific focuses on solutions for animal and human nutrition using an algae production system.
This technology produces highly concentrated products to support gut health in both animals and humans.
These products are available for sale in many regions globally, and Kemin will work to expand product registrations immediately.